FGFR2 Fusion
2 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Phase I/II Trial of Pemigatinib in Combination With Atezolizumab and Bevacizumab for Treatment of Advanced Cholangiocarcinoma With FGFR2 Fusion (NCT06439485) | M.D. Anderson Cancer Center | 2024-11-19 |
| Study to Evaluate the Efficacy and Safety of TT-00420 (Tinengotinib) in Cholangiocarcinoma (NCT04919642) | TransThera Sciences (Nanjing), Inc. | 2021-12-07 |
Track FGFR2 Fusion automatically
Every clearance here is in the API, with alerts when new ones post.